Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo

Despite the availability of numerous therapeutic substances that could potentially target CNS disorders, an inability of these agents to cross the restrictive blood–brain barrier (BBB) limits their clinical utility. Novel strategies to overcome the BBB are therefore needed to improve drug delivery....

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador, Ellaine, Kessler, Almuth F., Domröse, Dominik, Hörmann, Julia, Schaeffer, Clara, Giniunaite, Aiste, Burek, Malgorzata, Tempel-Brami, Catherine, Voloshin, Tali, Volodin, Alexandra, Zeidan, Adel, Giladi, Moshe, Ernestus, Ralf-Ingo, Löhr, Mario, Förster, Carola Y., Hagemann, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599321/
https://www.ncbi.nlm.nih.gov/pubmed/36291557
http://dx.doi.org/10.3390/biom12101348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599321/
https://www.ncbi.nlm.nih.gov/pubmed/36291557
http://dx.doi.org/10.3390/biom12101348

Ejemplares similares